{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:41:07Z","timestamp":1769607667757,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T00:00:00Z","timestamp":1352505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00296-012-2578-y","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T09:28:52Z","timestamp":1352453332000},"page":"1327-1331","source":"Crossref","is-referenced-by-count":27,"title":["Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life"],"prefix":"10.1007","volume":"33","author":[{"given":"Pelin","family":"Oktayoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serda","family":"Em","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Tahtasiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehtap","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demet","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Yazmalar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Nas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim","family":"Yard\u0131meden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriye","family":"Mete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,10]]},"reference":[{"key":"2578_CR1","unstructured":"Gardner DL (1992) Reactive and postinfective arthritis and seronegative spondyloarthropathy. In: Gardner DL (ed) Pathological basis of the connective tissue diseases. London, pp 763\u2013795"},{"key":"2578_CR2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaut.2009.02.010","volume":"32","author":"R P\u00f6ll\u00e4nen","year":"2009","unstructured":"P\u00f6ll\u00e4nen R, Sillat T, Pajarinen J et al (2009) Microbial antigens mediate HLA-B27 diseases via TLRs. J Autoimmun 32:172\u2013177","journal-title":"J Autoimmun"},{"key":"2578_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/path.1700710111","volume":"71","author":"B Cruickshank","year":"1956","unstructured":"Cruickshank B (1956) Lesions of cartilaginous joints in ankylosing spondylitis. J Pathol Bacteriol 71:73\u201384","journal-title":"J Pathol Bacteriol"},{"key":"2578_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/ard.30.3.213","volume":"30","author":"J Ball","year":"1971","unstructured":"Ball J (1971) Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 30:213\u2013223","journal-title":"Ann Rheum Dis"},{"key":"2578_CR5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/art.23260","volume":"58","author":"J Sieper","year":"2008","unstructured":"Sieper J, Appel H, Braun J et al (2008) Critical appraisal of assessment of structural damage in ankylosing spondylitis. Arthritis Rheum 58:649\u2013656","journal-title":"Arthritis Rheum"},{"key":"2578_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","volume":"81","author":"ME Bianchi","year":"2007","unstructured":"Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1\u20135","journal-title":"J Leukoc Biol"},{"key":"2578_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar2440","volume":"10","author":"DS Pisetsky","year":"2008","unstructured":"Pisetsky DS, Erlandsson-Harris H, Andersson U (2008) High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther 10:209","journal-title":"Arthritis Res Ther"},{"key":"2578_CR8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.10859","volume":"48","author":"N Taniguchi","year":"2003","unstructured":"Taniguchi N, Kawahara K, Yone K et al (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971\u2013981","journal-title":"Arthritis Rheum"},{"key":"2578_CR9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00296-010-1636-6","volume":"32","author":"C Chun yun ma","year":"2012","unstructured":"Chun yun ma C, MaJiao Y, Zhang J et al (2012) Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int 32:395\u2013402","journal-title":"Rheumatol Int"},{"key":"2578_CR10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","volume":"26","author":"M Yu","year":"2006","unstructured":"Yu M, Wang H, Ding A et al (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174\u2013179","journal-title":"Shock"},{"key":"2578_CR11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1152\/ajpcell.00401.2005","volume":"290","author":"JS Park","year":"2006","unstructured":"Park JS, Gamboni-Robertson F, He Q et al (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:917\u2013924","journal-title":"Am J Physiol Cell Physiol"},{"key":"2578_CR12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.192.4.565","volume":"192","author":"U Anderson","year":"2000","unstructured":"Anderson U, Wang H, Palmblad K et al (2000) High mobility group 1 protein (HMG 1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565\u2013570","journal-title":"J Exp Med"},{"key":"2578_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10067-006-0283-5","volume":"26","author":"A Bal","year":"2007","unstructured":"Bal A, Unlu E, Bahar G et al (2007) Comparison of serum IL-1, sIL-2R, IL-6 and TNF- alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 26:211\u2013215","journal-title":"Clin Rheumatol"},{"key":"2578_CR14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/rheumatology\/33.10.927","volume":"33","author":"J Gratacos","year":"1994","unstructured":"Gratacos J, Collado A, Fiella X et al (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheum 33:927\u2013931","journal-title":"Br J Rheum"},{"key":"2578_CR15","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1128\/MCB.00130-07","volume":"27","author":"N Taniguchi","year":"2007","unstructured":"Taniguchi N, Yoshida K, Ito T et al (2007) The stage specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol Cell Biol 27:5650\u20135663","journal-title":"Mol Cell Biol"},{"key":"2578_CR16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jcp.21268","volume":"214","author":"J Yang","year":"2008","unstructured":"Yang J, Shah R, Robling AG, Templeton E et al (2008) HMGB1 is a bone-active cytokine. J Cell Physiol 214:730\u2013739","journal-title":"J Cell Physiol"},{"key":"2578_CR17","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"2578_CR18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00296-003-0432-y","volume":"25","author":"Y Akkoc","year":"2005","unstructured":"Akkoc Y, Karatepe AG, Akar S et al (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280\u2013284","journal-title":"Rheumatol Int"},{"key":"2578_CR19","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"2578_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","volume":"62","author":"LC Doward","year":"2003","unstructured":"Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ et al (2003) Development of ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20\u201326","journal-title":"Ann Rheum Dis"},{"key":"2578_CR21","volume-title":"Translation and validation of the Turkish version of the ankylosing spondylitis quality of life (ASQoL) Questionnaire","author":"T Duruoz","year":"2008","unstructured":"Duruoz T, Doward L, Cerrahoglu L et al (2008) Translation and validation of the Turkish version of the ankylosing spondylitis quality of life (ASQoL) Questionnaire. Abstract Book, EULARl"},{"key":"2578_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331\u2013342","journal-title":"Nat Rev Immunol"},{"key":"2578_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L et al (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38:499\u2013505","journal-title":"Arthritis Rheum"},{"key":"2578_CR24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"J Braun","year":"2010","unstructured":"Braun J, van den Berg R, Baraliakos X et al (2010) 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896\u2013904","journal-title":"Ann Rheum Dis"},{"key":"2578_CR25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, Bloom O, Zhang M et al (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248\u2013251","journal-title":"Science"},{"key":"2578_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00024382-200115040-00001","volume":"15","author":"H Yang","year":"2001","unstructured":"Yang H, Wang H, Tracey KJ (2001) HMG-1 rediscovered as a cytokine. Shock 15:247\u2013253","journal-title":"Shock"},{"key":"2578_CR27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2796.2003.01303.x","volume":"255","author":"U Andersson","year":"2004","unstructured":"Andersson U, Erlandsson-Harris H (2004) HMGB1 is a potent trigger of arthritis. J Intern Med 255:344\u2013350","journal-title":"J Intern Med"},{"key":"2578_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3899\/jrheum.100469","volume":"38","author":"S Assassi","year":"2011","unstructured":"Assassi S, Reveille JD, Arnett FC et al (2011) Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5. J Rheumatol 38:87\u201398","journal-title":"J Rheumatol"},{"key":"2578_CR29","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/art.21969","volume":"54","author":"M Ek","year":"2006","unstructured":"Ek M, Popovic K, Harris HE et al (2006) Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren\u2019s syndrome. Arthritis Rheum 54:2289\u20132294","journal-title":"Arthritis Rheum"},{"key":"2578_CR30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3346\/jkms.2011.26.5.697","volume":"26","author":"JK Ahn","year":"2011","unstructured":"Ahn JK, Cha HS, Bae EK et al (2011) Extracellular high-mobility group box 1 is increased in patients with Beh\u00e7et\u2019s disease with intestinal involvement. J Korean Med Sci 26:697\u2013700","journal-title":"J Korean Med Sci"},{"key":"2578_CR31","first-page":"566","volume":"44","author":"B Liu","year":"2005","unstructured":"Liu B, Guo CY, Liu WQ et al (2005) The value of erythrocyte sedimentation rate and C-reactive protein in evaluating disease activity in ankylosing spondylitis. Zhonghua Nei Ke Za Zhi 44:566\u2013569","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2578_CR32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.SMJ.0000066946.56322.3C","volume":"97","author":"K Yildirim","year":"2004","unstructured":"Yildirim K, Erdal A, Karatay S et al (2004) Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis. South Med J 97:350\u2013353","journal-title":"South Med J"},{"key":"2578_CR33","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980\u2013984","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2578-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2578-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:21:42Z","timestamp":1559042502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2578-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2578"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2578-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,10]]}}}